Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 20, 2016
Filling the Knowledge Gap in Diabetes Management During Ramadan: the Evolving Role of Trial EvidenceSaud Al Sifri, Kashif Rizvi
Indian Journal of Endocrinology and Metabolism|January 10, 2014
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Taif, Saudi Arabia cohort of the A1chieve studyHelmy El Gendy, Saud Al Sifri, Mohamed Ghazy
Diabetes Research and Clinical Practice|May 25, 2015
Incidence of hypoglycemia in patients with type 2 diabetes treated with gliclazide versus DPP-4 inhibitors during Ramadan: A meta-analytical approachJean Claude Mbanya, Saud Al-Sifri, Aly Abdel-Rahim, et al.
Diabetes Research and Clinical Practice|January 23, 2018
Direct and indirect health economic impact of hypoglycaemia in a global population of patients with insulin-treated diabetesRonnie Aronson, Gagik Galstyan, Margalit Goldfracht, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 9, 2024
Safety and Effectiveness of Concomitant iGlarLixi and SGLT-2i Use in People with T2D During Ramadan Fasting: A SoliRam Study Sub-analysisMohamed Hassanein, Rachid Malek, Saud Al Sifri, et al.
Saudi Medical Journal|January 12, 2023
The prevalence of cardiovascular disease in adults with type 2 diabetes mellitus in Saudi Arabia - CAPTURE studyAbdullah M Alguwaihes, Amani Alhozali, Moataz M Yahia, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 16, 2026
Summary of Research: Safety and Effectiveness of Concomitant iGlarLixi and SGLT-2i Use in People with T2D During Ramadan Fasting: A SoliRam Study Sub-analysisMohamed Hassanein, Rachid Malek, Saud Al Sifri, et al.
Diabetes & Metabolic Syndrome|January 21, 2023
Real-world safety and effectiveness of iGlarLixi in people with type 2 diabetes who fast during Ramadan: The SoliRam observational studyMohamed Hassanein, Rachid Malek, Inass Shaltout, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 27, 2023
Optimizing Diabetes Management Using a Low-Calorie Diet in Saudi Arabia: A Cost-Benefit AnalysisSaud Al Sifri, Raed Aldahash, Daniel-Antonio de Luis Roman, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 3, 2022
Safety and Effectiveness of Insulin Glargine 300 U/mL in Participants with Type 2 Diabetes Who Fast During Ramadan in The Gulf Region: A Subgroup Analysis of the Real-World ORION StudyRayaz A Malik, Tarik Elhadd, Abdulnabi Alattar, et al.
Pageof 3